Status:
COMPLETED
Enhancing Community Capacity to Improve Cancer Care Delivery
Lead Sponsor:
Stanford University
Conditions:
End of Life
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Undertreated patient symptoms and resulting acute care use require approaches that improve symptom-burden. Previously a a lay health worker (LHW)-led symptom screening intervention was developed for p...
Detailed Description
From 11/1/2016 - 9/30/2018, all newly diagnosed Medicare Advantage enrollees with solid or hematologic malignancies were enrolled in the intervention. Outcomes were compared outcomes to patients in th...
Eligibility Criteria
Inclusion
- Newly diagnosed with cancer
- Diagnosis of relapse or progressive disease (any cancer diagnosis) as identified by imaging or biopsy and confirmed by physician.
- Must be 18 years or older.
- Must have capacity to verbally consent
Exclusion
- Inability to consent to the study due to lack of capacity as documented by the referring physician.
Key Trial Info
Start Date :
November 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
832 Patients enrolled
Trial Details
Trial ID
NCT04107116
Start Date
November 1 2016
End Date
September 30 2021
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oncology Institute for Hope and Innovation
Los Angeles, California, United States